http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4717727-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5c24684033fba97d1ad845ce453a57e3
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-79
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-455
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-79
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4402
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
filingDate 1985-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1988-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_397365f74e4f57824674239737468a40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b041dbf823acfbd1f7ff059719c1a478
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91449a31c05183a2f33db1cbeae659bb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_66d5d9287921a50bbd2df51563cbf160
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d934d804325870bddd4fcb384a0dc02a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cba59b605942f3c6c611c6151f8c59b3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ea5bcaa3432b555424e48a24d2c5450
publicationDate 1988-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-4717727-A
titleOfInvention Esters of pyridine-2,4- and 2,5-dicarboxylic acid as medicaments for the inhibition of proline hydroxylase and lysine hydroxylase
abstract Esters of pyridine-2,4- and -2,5-dicarboxylic acid act as inhibitors of proline hydroxylase and lysine hydroxylase and are suitable as fibrosuppressants and immunosuppressants, in particular for the treatment of disturbances of the metabolism of collagen and collagen-like substances and of the biosynthesis of Clq.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009215837-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5614537-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9107847-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5401510-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5525349-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5401509-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5356909-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5624893-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5482953-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010105741-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10835468-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007231330-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005059711-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10788201-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0158998-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7208153-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5271939-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2020109852-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10085931-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4904675-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10857087-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5589184-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5589185-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005118177-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5646272-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7863301-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5360611-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5124392-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5580570-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5582835-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5607954-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5004748-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5573775-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4939135-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11045407-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5665373-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10772819-B2
priorityDate 1984-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2809146-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2852519-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4457936-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412058
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1474
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID150779
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129157877
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID568728
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127522966
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226592999
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135616172
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393830
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393829
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45051774
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397484
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127605026

Total number of triples: 81.